We are live on ! Find out more

22 hedge funds and large institutions have $43.5M invested in Evotec in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

5% more funds holding

Funds holding: 2122 (+1)

0.05% more ownership

Funds ownership: 1.35%1.4% (+0.05%)

24% less capital invested

Capital invested by funds: $57.3M → $43.5M (-$13.8M)

Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
7
Closed
2
Calls
Puts
Net Calls
Net Calls Change

EVO Hedge Fund Activity: Q3 2022 in Review

22 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in Evotec (EVO) for Q3 2022, worth a combined $43.5M — down 24% from $57.3M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new EVO positions and 2 closed out — a net gain of 1 holder — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Federated Hermes, adding an estimated $4.6M. The largest seller was Optiver Holding, exiting entirely with an estimated $1.98M sold.

  • 22 institutional investors held Evotec (EVO) as of Q3 2022, up from 21 in Q2 2022.
  • Funds reported $43.5M of Evotec stock for Q3 2022, down 24% quarter-over-quarter.
  • 3 funds opened new Evotec positions in Q3 2022 and 2 closed out, a net change of +1 holder.
  • The largest Evotec buyer in Q3 2022 was Federated Hermes, an estimated $4.6M added.
  • The largest Evotec seller in Q3 2022 was Optiver Holding, an estimated $1.98M sold.

Based on aggregated 13F filings for Q3 2022.